September 11, 2021
Oncopeptides presents phase 3 OCEAN study results at the IMW meeting
Media
September 09, 2021
Study results on FORTIFY are inconclusive
September 09, 2021
Webcast for presentation of OCEAN data presented at IMW
September 09, 2021
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.
September 02, 2021
Regulatory update from US Food and Drug Administration
August 27, 2021
Oncopeptides presents new data from OCEAN and PORT study – abstracts online
August 27, 2021
Targovax ASA: Abstract on ONCOS-102 phase 1 trial in advanced PD1 refractory melanoma is accepted at ESMO Congress
August 27, 2021
Vicore strengthens its management team
August 27, 2021
Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021
August 26, 2021
Interim report April – June 2021
